The impacts of c-reactive protein and atrial fibrillation on carotid atherosclerosis and ischemic stroke in patients with suspected ischemic cerebrovascular disease: A single-center retrospective observational cohort study

Korean Circulation Journal

Volumn 43, Issue 12, 2013, Pages 796-803

  Ock, So Young ^a   Cho, Kyoung Lm ^a   Kim, Hyung Joon ^a   Lee, Nae Young ^a   Kim, Eun Jeong ^a   Kim, Nam Kyu ^a   Lee, Weon Hyoung ^a   Yeo, Go Eun ^a   Heo, Jae Joon ^a   Han, You Jin ^a   Cha, Tae Joon ^a  

^a Kasin University College of Medicine   (South Korea)

Author keywords

Atrial fibrillation; C reactive protein; Carotid atherosclerosis.

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ARTERIOGRAPHY; CAROTID ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

EID: 84892604662     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2013.43.12.796     Document Type: Article

References (28)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. (Pubitemid 34212626)
2. Shah PK. Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Clin 1999;17:271-81. (Pubitemid 29277863)
3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131-8. (Pubitemid 16024121)
4. Ross R. Atherosclerosis-an inflammatory disease. N Eng l J Med1999; 340:115-26.
5. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109(25 Suppl 1):IV6-19.
6. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of corpnary heart disease. N Engl J Med 2004;350:1387-97. (Pubitemid 38419992)
7. Koenig W, Löwel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109:1349-53. (Pubitemid 38387819)
8. Lombardo A, Biasucci LM, Lanza GA, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004; 109:3158-63.
9. Winbeck K, Kukla C, Poppert H, Klingelhöfer J, Conrad B, Sander D. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002; 13: 57-63. (Pubitemid 34124172)
10. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003;38:1018-24. (Pubitemid 37409637)
11. O'Leary DH, Polak JF, Kronmal RA, ManolioTA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22. (Pubitemid 29024679)
12. Folsom AR, Pankow JS, Tracy RP, et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88:112-7. (Pubitemid 32607694)
13. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vase Biol 1997;17:2167-76. (Pubitemid 28057118)
14. Cai H, Li Z, Goette A, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 2002; 106:2854-8. (Pubitemid 35396987)
15. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10. (Pubitemid 37553570)
16. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8. (Pubitemid 27513431)
17. Frustaci A, Chimenti C, Belloeci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4. (Pubitemid 27344221)
18. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91. (Pubitemid 33139098)
19. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008 ;359:219 5-207.
20. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intimamedia thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34:290-6.
21. Nagai Y, Kitagawa K, Yamagami H, et al. Carotid artery intima-media thickness and plaque score for the risk assessment of stroke subtypes. Ultrasound Med Biol 2002;28:1239-43. (Pubitemid 35418248)
22. Blackburn R, Giral P, Bruckert E, et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vase Biol 2001;21:1962-8. (Pubitemid 34219748)
23. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105:2019-23. (Pubitemid 34465262)
24. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10.
25. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
26. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med;306:1018-22.
27. Cermak J, Key NS, Bach RR, Balia J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20. (Pubitemid 23206115)
28. Hadjiev Dl, Mineva PP. A reappraisal of the definition and pathophysiology of the transient ischemic attack. Med Sci Monit 2007;13:RA50-3.